-
Published04/08/2026
-
Deadline14/09/2026
-
Today14/09/2026
-
Opening of tenders14/09/2026
Utilities
- indicates text translated automatically in your browsing language
Public procurement of combined diphtheria-tetanus-cellular pertussis, inactivated polio vaccine (DTPa-IPV) - tetravalent
Estimated minimum value excluding VAT: 34,764,000,00 lei Maximum estimated value without VAT: 69,528,000,00 lei Frequency of awarding subsequent contracts: depending on the needs and financial availabilities allocated for this purpose. The quantity covered by the framework agreement is a minimum of 400,000 doses of the combined diphtheria-tetanus-cellular pertussis, inactivated polio (DTPa-IPV)-tetravalent vaccine and a maximum of 800,000 doses of the combined diphtheria-tetanus-cellular pertussis, inactivated polio (DTPa-IPV)-tetravalent vaccine. The quantity that could be the subject of a subsequent contract is at least 100,000 doses, and the maximum quantity is 200,000 doses. The estimated value of the largest subsequent contract is RON 17 382 020.00 excluding VAT
https://www.e-licitatie.ro
https://www.e-licitatie.ro
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.